Upgrade to SI Premium - Free Trial

Stifel Reiterates Buy Rating on Abbott Labs (ABT)

April 14, 2025 7:33 AM
Stifel analyst Rick Wise reiterated a Buy rating and $135.00 price target on Abbott Labs (NYSE: ABT).The analyst commented, “In ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles